Geburtshilfe Frauenheilkd 2015; 75(4): 339-341
DOI: 10.1055/s-0035-1545958
Statement
GebFra Science
Georg Thieme Verlag KG Stuttgart · New York

Should Fallopian Tubes Be Removed During Hysterectomy Procedures? – A Statement by AGO Ovar

Sollen die Tuben im Rahmen der Hysterektomie entfernt werden? – Ein Statement der AGO Ovar
M. Pölcher
1   Frauenklinik Taxisstraße, Rotkreuzklinikum München, Munich
,
S. Hauptmann
2   Institut für Pathologie, Krankenhaus Düren, Düren
,
C. Fotopoulou
3   West London Gynaecological Cancer Centre and Ovarian Cancer Action Research Centre Imperial College Healthcare Trust London, London
,
B. Schmalfeldt
4   Frauenklinik des Klinikums rechts der Isar der Technischen Universität München, Munich
,
I. Meinhold-Heerlein
5   Klinik für Gynäkologie und Geburtsmedizin, Universitätsklinikum RWTH Aachen, Aachen
,
A. Mustea
6   Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universitätsmedizin Greifswald, Greifswald
,
I. Runnebaum
7   Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena
,
J. Sehouli
8   Benjamin Franklin Charité Comprehensive Cancer Center (CCCC) Charité/Universitätsmedizin Berlin Charité, Berlin
,
for the Kommission Ovar of the Gynecologic Oncology Study Group (AGO) › Author Affiliations
Further Information

Publication History

Publication Date:
19 May 2015 (online)

Introduction

The detection of premalignant cells in the epithelia of the fallopian tubes has revolutionized the theories on the genesis of ovarian cancer. Occurrence of serous tubal intraepithelial carcinomas (STIC) has been established in carriers of the germline mutation of the BRCA1/2 gene, with STICs now considered as a possible origin of serous high-grade carcinomas which frequently occur in this patient population. Bilateral salpingo-oophorectomy leads to a significant decrease in the risk of developing this carcinoma. It is recommended that this prophylactic surgery be performed between the age of 40 and 45 years.

Removal of the fallopian tubes has been propagated analogously in women with no proven genetic or identifiable familial risk of ovarian cancer. Fallopian tube removal has been proposed during surgery for benign disease, for example in women in whom hysterectomy is indicated. Such “prophylactic” or “opportunistic” salpingectomy procedures could prevent carcinoma development in later years. Critics warn that such an intervention could result in inadequate blood supply to the ovaries, resulting in morbidity associated with early hormone deficiency. It is still unclear how effective opportunistic salpingectomy could be as a primary prevention strategy and how such a strategy should best be implemented.

 
  • References

  • 1 Crum CP, Drapkin R, Miron A et al. The distal Fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 2007; 19: 3-9
  • 2 Piek JM, van Diest PJ, Zweemer RP et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001; 195: 451-456
  • 3 Medeiros F, Muto MG, Lee Y et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006; 30: 230-236
  • 4 Kindelberger DW, Lee Y, Miron A et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007; 31: 161-169
  • 5 Folkins AK, Jarboe EA, Roh MH et al. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 2009; 113: 391-396
  • 6 Powell CB, Chen LM, McLennan J et al. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer 2011; 21: 846-851
  • 7 Chivukula M, Neimeier LA, Edwards R et al. Carcinomas of distal Fallopian tube and their association with tubal intraepithelial carcinoma: do they share a common “precursor” lesion? Loss of heterozygosity and immunohistochemical analysis using PAX 2, WT-1, and P53 markers. ISRN Obstet Gynecol 2011; 2011: 858647
  • 8 Paik DY, Janzen DM, Schafenacker AM et al. Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells 2012; 30: 2487-2497
  • 9 Tang S, Onuma K, Deb P et al. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases. Int J Gynecol Pathol 2012; 31: 103-110
  • 10 Bijron JG, Seldenrijik CA, Zweemer RP et al. Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis. Am J Surg Pathol 2013; 37: 1123-1130
  • 11 Gao FF, Bhargava R, Yang H et al. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?. Hum Pathol 2013; 44: 1534-1543
  • 12 Lee S, Nelson G, Duan Q et al. Precursor lesions and prognostic factors in primary peritoneal serous carcinoma. Int J Gynecol Pathol 2013; 32: 547-555
  • 13 Reitsma W, de Bock GH, Oosterwijk JC et al. Support of the ʼFallopian tube hypothesisʼ in a prospective series of risk-reducing salpingo-oophorectomy specimens. Eur J Cancer 2013; 49: 132-141
  • 14 Callahan MJ, Crum CP, Medeiros F et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 2007; 25: 3985-3990
  • 15 Przybycin CG, Kurman RJ, Ronnett BM et al. Are all pelvic (nonuterine) serous carcinomas of tubal origin?. Am J Surg Pathol 2010; 34: 1407-1416
  • 16 Jacoby VL, Grady D, Wactawski-Wende J et al. Oophorectomy vs. ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Womenʼs Health Initiative Observational Study. Arch Intern Med 2011; 171: 760-768
  • 17 Parker WH, Feskanich D, Broder MS et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nursesʼ health study. Obstet Gynecol 2013; 121: 709-716
  • 18 Rocca WA, Grosshardt BR, de Andrade M et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006; 7: 821-828
  • 19 Repasy I, Lendvai V, Koppan A et al. Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2009; 144: 64-67
  • 20 Sezik M, Ozkaya O, Demir F et al. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 2007; 33: 863-869
  • 21 Petri Nahás EA, Pontes A, Nahas-Neto J et al. Effect of total abdominal hysterectomy on ovarian blood supply in women of reproductive age. J Ultrasound Med 2005; 24: 169-174
  • 22 Findley AD, Siedhoff MT, Hobbs KA et al. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. Fertil Steril 2013; 100: 1704-1708
  • 23 Dar P, Sachs GS, Strassburger D et al. Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 2000; 15: 142-144
  • 24 Vorwergk J, Radosa MP, Nicolaus K et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol 2014; 140: 859-865
  • 25 Guldberg R, Wehberg S, Wessel Skovlund C et al. Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977–2010. BMJ Open 2013; 3: e002845
  • 26 Müller A, Thiel FC, Renner SP et al. Hysterectomy-a comparison of approaches. Dtsch Arztebl Int 2010; 107: 353-359
  • 27 Pölcher M, Hauptmann S, Fotopoulou CH et al. Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO. Arch Gynecol Obstet 2015; DOI: 10.1007/s00404-015-3697-y.